Correlation Between NRBO Old and Virax Biolabs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NRBO Old and Virax Biolabs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NRBO Old and Virax Biolabs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NRBO Old and Virax Biolabs Group, you can compare the effects of market volatilities on NRBO Old and Virax Biolabs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NRBO Old with a short position of Virax Biolabs. Check out your portfolio center. Please also check ongoing floating volatility patterns of NRBO Old and Virax Biolabs.

Diversification Opportunities for NRBO Old and Virax Biolabs

0.58
  Correlation Coefficient

Very weak diversification

The 3 months correlation between NRBO and Virax is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding NRBO Old and Virax Biolabs Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virax Biolabs Group and NRBO Old is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NRBO Old are associated (or correlated) with Virax Biolabs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virax Biolabs Group has no effect on the direction of NRBO Old i.e., NRBO Old and Virax Biolabs go up and down completely randomly.

Pair Corralation between NRBO Old and Virax Biolabs

Given the investment horizon of 90 days NRBO Old is expected to generate 0.77 times more return on investment than Virax Biolabs. However, NRBO Old is 1.29 times less risky than Virax Biolabs. It trades about -0.02 of its potential returns per unit of risk. Virax Biolabs Group is currently generating about -0.09 per unit of risk. If you would invest  198.00  in NRBO Old on December 29, 2024 and sell it today you would lose (9.00) from holding NRBO Old or give up 4.55% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy34.43%
ValuesDaily Returns

NRBO Old  vs.  Virax Biolabs Group

 Performance 
       Timeline  
NRBO Old 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days NRBO Old has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental drivers, NRBO Old is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
Virax Biolabs Group 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Virax Biolabs Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

NRBO Old and Virax Biolabs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NRBO Old and Virax Biolabs

The main advantage of trading using opposite NRBO Old and Virax Biolabs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NRBO Old position performs unexpectedly, Virax Biolabs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virax Biolabs will offset losses from the drop in Virax Biolabs' long position.
The idea behind NRBO Old and Virax Biolabs Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
FinTech Suite
Use AI to screen and filter profitable investment opportunities
CEOs Directory
Screen CEOs from public companies around the world